DR
MJN

David Rolfe’s Mead Johnson Nutrition Company MJN Stock Holding History

David Rolfe’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,451,913
Closed -$103M – 39
2016
Q4 		$103M Sell
1,451,913
-262,106
-15% -$19.5M 2.51% 20
2016
Q3 		$135M Sell
1,714,019
-869,701
-34% -$74.2M 2.84% 19
2016
Q2 		$234M Sell
2,583,720
-276,164
-10% -$23.4M 4.75% 9
2016
Q1 		$243M Sell
2,859,884
-277,738
-9% -$20.7M 4.41% 13
2015
Q4 		$248M Sell
3,137,622
-359,539
-10% -$28.3M 4.25% 13
2015
Q3 		$246M Buy
3,497,161
+767,009
+28% +$63.1M 3.58% 15
2015
Q2 		$246M Buy
2,730,152
+135,986
+5% +$13.1M 3.3% 16
2015
Q1 		$261M Sell
2,594,166
-21,626
-0.8% -$2.18M 3.5% 15
2014
Q4 		$263M Buy
2,615,792
+221,677
+9% +$22.1M 3.55% 17
2014
Q3 		$230M Buy
2,394,115
+12,270
+0.5% +$1.16M 3.72% 13
2014
Q2 		$222M Buy
2,381,845
+66,509
+3% +$5.82M 3.87% 13
2014
Q1 		$192M Buy
+2,315,336
New +$188M 3.56% 14

Other funds holding MJN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

David Rolfe's MJN Position: Q1 2017 in Review

David Rolfe sold out of Mead Johnson Nutrition Company (MJN) in Q1 2017, closing a stake of 1,451,913 shares — an estimated $103M sold.

David Rolfe first reported a position in MJN in Q1 2014 and held it in 12 quarters. The position peaked at $263M in Q4 2014. 533 funds tracked by Wall St. Rank hold MJN as of Q1 2017.

  • David Rolfe reported no remaining Mead Johnson Nutrition Company position as of Q1 2017 after selling out during the quarter.
  • David Rolfe sold 1,451,913 Mead Johnson Nutrition Company shares in Q1 2017, an estimated $103M.
  • David Rolfe first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 12 quarters.
  • David Rolfe's Mead Johnson Nutrition Company position peaked at $263M in Q4 2014.
  • 533 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q1 2017.

Based on Wedgewood Partners's 13F filing for Q1 2017, filed 15 May 2017.